Landing Page PDF - (With Comments)-2 1

Regenerative Cell Therapy
For Facet Joint Syndrome

Back pain is often caused by Facet Joint Syndrome (FJS).
Check your eligibility below.

img

Eligibility Requirements

img

Participants must be between 18 and 75 years old

img

Experiencing lower back
pain, or lack of back strength

img

Diagnosed with
Facet Joint Syndrome

About the Trial

  • The focus of this study is to investigate the therapeutic benefit of autologous adipose-derived regenerative cells in patients with Faced Joint Syndrome.
  • The hypothesis of this trial is that the use of adult-adipose derived regenerative cells as a treatment of Faced Joint Syndrome will induce healing and increased function and strength in the affected lower back. *
  • There is no cost to study participants and reimbursement is available for time and travel.
  • More information can be found at www.clinicaltrials.gov.

* The use of regenerative cells is investigational. We are studying the safety and effectiveness of this treatment compared to steroid injections.

img
img

About Facet Joint Syndrome

  • At least two and a half million people endure chronic back pain, and facet joint syndrome is one of the leading causes of this condition.
  • Facet joint syndrome is associated with the inflammation of a person’s facet joint, which leads to degeneration and cartilage loss.
  • Many current treatment options to address facet joint syndrome, such as oral pain medication, steroid injection, and nerve ablation, focus on its symptoms rather than its root cause and therefore provide only short-term relief rather than healing.

Post Treatment Expectations

Following the procedure day, you’ll have 4 follow-up visits with the physician who performed the procedure:

These visits will include a physical exam, questions about your health history and medications, surveys, lab testing and radiographic exams.

img
2 weeks

1st Follow-up visit:

  • Physical Exam
  • Lab Test
  • Pain/Function Evaluation
img
6 weeks

2nd Follow-up visit:

  • Physical Exam
  • Pain/Function Evaluation
img
12 weeks

3rd Follow-up visit:

  • Physical Exam
  • Pain/Function Evaluation
img
26 weeks

4th Follow-up visit:

  • Physical Exam
  • Pain/Function Evaluation
  • MRI of the back
img

Who is conducting this
clinical trial?

  • InGeneron is a biotechnology company creating
    innovative, cell-based technologies for the next
    generation of medicine.
  • For the past 20 years, we have focused on helping
    patients impacted by orthopedic conditions.
  • We are dedicated to developing therapies supported
    by quality clinical evidence and approved by the FDA.

Clinical Trial Location

Florida

Dr. Manish Gupta

Sports and Orthopedic Center 6280 W. Sample Road Suite 202

Coral Springs, FL 33067

Email: viveks@pioneerclinical.com

Tel: +1 (954) 204 0052

img

Contact your nearest clinical site to learn more.

Frequently Asked Questions

What are stem cells?

Stem cells serve as the starting material of the body and the precursor to all other cell types. Stem cells are unspecialized cells capable of transforming into a range of other cell types but also able to replicate themselves to produce more stem cells. The body uses stem cells to heal and regenerate tissues by activating the stem cells to mature into the type of cell needed by the body.

What are adipose-derived regenerative cells (ADRCs)?
  • Regenerative cells are cell types that naturally promote tissue regeneration and homeostasis by facilitating the generation of new cells to replace old or injured cells in a particular tissue. Adipose-derived regenerative cells, also known as Stromal Vascular Fraction, are cells isolated from adipose (fat) tissue, where they are found in high concentrations. Regenerative cells include stem cells, notably vaPS cells, and MSCs, which can mature into multiple cell types, progenitor cells, macrophages, and other cell types that promote tissue regeneration and healing. These cells work together through a complex system of signaling, resulting in synergistic healing effects that are greater than the effect that any one cell type can have on its own.
  • Multiple studies show that ADRCs can be effective in treating a variety of soft tissue and bone conditions and have a high safety profile.
How do I find out if I qualify for the study?

If you are interested in joining this study please use the contact button at the top of the page to send us a message or reach out to your nearest clinical site using the map above.